🔗 Share this article

A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.

Experimental Treatment Acquiring Popularity Online

The experimental drug, which is still in research studies, is being promoted by social media influencers for its alleged weight-reducing properties. Followers are urged to contact these profiles directly for source information, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Separately, a robust trade exists on Telegram, where groups with numerous of members share “before and after” images, injection guides and assertions of next-day UK delivery. Sellers market the substance there before redirecting buyers to WhatsApp for transactions.

Understanding The Experimental Drug

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Professionals Voice Concerns

However, doctors and pharmacists have cautions that the sale of what is still an unapproved medication in the UK is a cause for concern and could lead to users injecting substances of uncertain source.

Some experts stated the popularity for retatrutide could be linked to the increasing price of approved slimming products such as Mounjaro.

Legal Status and Enforcement

Selling the unapproved drug on social media or Telegram is illegal in the UK, as it is an unapproved medication that must not be marketed or supplied for personal consumption under the British medical regulations.

Some influencers try to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still breach medicines, marketing, and consumer laws, potentially leading to fines, prosecution or imprisonment.

Platform Response and Material Elimination

According to the social media company, the service has removed violative material and prohibited related hashtags and search suggestions. The organization stated it was dedicated to maintaining the platform safe and investing in enhancing enforcement strategies.

Digital Marketplace Activities

Investigations also discovered groups with up to 9,000 members marketing retatrutide using Telegram's integrated discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays groups with thousands of members, populated with images of weight loss, glowing reviews and step-by-step instructions for preparing or administering at residence.

Within moments of entering one group, a vendor posted WhatsApp details, where the majority of transactions take place. The vendor provided an guidebook and guaranteed delivery within two days. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about body mass, medical conditions or past usage.

Product Information and Costs

Inside these communities, posts show dark colored parcels with Royal Mail stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at residence with purified liquid, or ready-to-use injectors typically sold at 160 pounds for 20mg. When asked how much time a pen should be used, vendors give contradictory responses ranging from a several days to “depends on your body”.

Platform Oversight and Security Measures

A representative for the messaging service said it actively monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering materials they can’t verify. Even if the research behind retatrutide is valid, these online products may not include what they advertise,” stated Jason Murphy, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in demand to recent price rises for approved slimming drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake injections are extremely risky. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she said.

Her team has previously encountered individuals injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a company experimental substance not yet authorized … may subject users to possibly serious medical dangers”.